Testing with Novel Biomarkers of Acute Kidney Injury
Through our stringent process of exploration, validation and clinical trials, we create tools that health care professionals can trust and rely on, right from the start. Using novel biomarkers of acute kidney injury (AKI) and other disease states, our tools provide clinical support for assessment of the critically ill patient. Our first offering, the NephroCheck® Test, performed on the Astute140® Meter, accurately assesses risk of AKI. And because it produces results within minutes, it may lead to earlier and improved patient treatment.
Ready to review the results? Read the Astute Tools.
REVIEW ASTUTE TOOLS